(NCPAD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer - https://doi.org/10.1186/s41021-023-00291-4) -
(Metformin suppresses proliferation and glycolysis of gastric cancer by modulating ADAMTS12 - https://doi.org/10.1186/s41021-023-00296-z)